Lithium & Mood Stabilizers: Conference Sessions

Roy Perlis

Maintenance treatment strategies for keeping bipolar disorder stable over time.

Bipolar Disorder

Mark A. Frye

Managing each phase of bipolar disorder with advanced pharmacologic strategies.

Bipolar Disorder

Erica Mann

Reviews lithium's evidence for reducing suicidality in adolescent bipolar disorder with practical prescribing and monitoring guidance. Pharmacology-eligible.

Bipolar DisorderChild & AdolescentSuicide & Self-Harm

Jonathan M. Meyer

Reviews older psychotropics with limited modern utility and current best practices for clozapine and lithium.

ClozapineDeprescribing & Polypharmacy

Galila Agam · Olav B Smeland · Frank Bellivier · Caterina del Mar Bonnin Roig

Sex differences, genomics, lithium-response prediction (R-LiNK), and cognitive resilience in bipolar disorder.

Bipolar DisorderPharmacogenomics & Precision Psychiatry

Jonathan M. Meyer

Practical deep dive on lithium's mechanisms and dosing precision, including monitoring, toxicity mitigation, adherence, and use in special populations.

Drug Interactions & Safety

Joseph Goldberg

Advanced guidance on sequencing lithium, anticonvulsants, and atypical antipsychotics in bipolar disorder, with case vignettes on inadequate response, intolerability, and polypharmacy.

Antipsychotic PrescribingBipolar DisorderDeprescribing & Polypharmacy

Jill Harkavy-Friedman · Cory Weissman

Reviews treatments with demonstrated anti-suicidal benefit — lithium, clozapine, ECT, and CBT-based approaches — within a structured framework for individualized prevention planning. Developed with the American Foundation for Suicide Prevention.

ClozapineNeuromodulation (ECT, TMS)Suicide & Self-Harm

Mark Zimmerman · Shelley Matthews

Advanced review of switching protocols, cross-tapering, and augmentation options — lithium, T3, atypicals, dextromethorphan/bupropion, vortioxetine — for patients with incomplete antidepressant response.

DepressionNovel AntidepressantsTreatment-Resistant Depression